首页> 外文期刊>Stereotactic and Functional Neurosurgery: Official Journal of the World Society for Stereotactic and Functional Neurosurgery >Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale.
【24h】

Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale.

机译:面肌痉挛的微血管减压术后的手术效果和生活质量的改善:使用经过验证的疾病特异性量表进行的病例系列评估。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Hemifacial spasm (HFS) is a movement disorder characterized by intermittent, involuntary clonic or tonic-clonic contractions of muscles innervated by the ipsilateral facial nerve. Recent studies have documented change in quality of life after HFS management with botulinum toxin injection. However, we failed to locate any study that documented change in quality of life after surgical management with retrosigmoid microvascular decompression (MVD). METHODS: Our study objectives were 3-fold. Firstly, to use a disease-specific, validated quality of life assessment scale to document any change in quality of life after MVD for HFS. Secondly, to determine the time period in which the majority of patients undergoing MVD could be expected to benefit from surgery. Finally, to determine factors affecting the postoperative quality of life following MVD. A retrospective analysis of HFS patients treated with MVD at a single institution by a single surgeon (K.J.B.) between January 2000 and December 2007 was undertaken. A modification of a previously developed validated disease-specific quality of life assessment scale that included the addition of a parameter for difficulty in sleep was used to assess quality of life before and after surgery. RESULTS: A total of 21 patients (14 female and 7 male) underwent treatment as specified. Eighty-five percent (17/20) of the patients reported prolonged remission of symptoms (mean follow-up period = 4.15 years). Five percent (1/20) reported occasional recurrence of twitches. The overall mean quality of life score improved from 11.1 preoperatively to 2.2 postoperatively. CONCLUSIONS: MVD offers significant and prolonged improvement in quality of life for the HFS patients we studied, as measured using a disease-specific, validated quality of life assessment scale. Postoperative quality of life, however, was strongly influenced by both the success of surgery in resolving the symptoms and the absence of any permanent complications of surgery.
机译:背景:面肌痉挛(HFS)是一种运动障碍,其特征是由同侧面神经支配的肌肉间歇性,非自愿性阵挛性或强直性阵挛性收缩。最近的研究表明,注射肉毒杆菌毒素进行HFS治疗后,生活质量发生了变化。但是,我们未能找到任何记录有乙状窦后微血管减压术(MVD)手术治疗后生活质量改变的研究。方法:我们的研究目标是3倍。首先,要使用针对疾病的,经过验证的生活质量评估量表来记录HFS MVD后生活质量的任何变化。其次,确定可以预期接受MVD的大多数患者将从手术中受益的时间段。最后,确定影响MVD术后术后生活质量的因素。回顾性分析了2000年1月至2007年12月期间由一位外科医生(K.J.B.)在单个机构接受MVD治疗的HFS患者。对先前开发的经过验证的特定疾病生活质量评估量表的修改(包括添加睡眠困难参数)用于评估手术前后的生活质量。结果:总共21例患者(14名女性和7名男性)接受了指定的治疗。百分之八十五(17/20)的患者报告症状缓解时间延长(平均随访时间= 4.15年)。百分之五(1/20)的人偶发抽搐。总体平均生活质量得分从术前的11.1提高到术后的2.2。结论:MVD为我们研究的HFS患者提供了显着且长期的生活质量改善,这是通过使用一种针对疾病的,经过验证的生活质量评估量表来衡量的。但是,手术能否成功治愈症状以及是否没有永久性手术并发症都对术后生活质量产生了重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号